Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
NCT04239963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-10-30
Summary
The overarching goal of the present study is to evaluate the effect of a subanesthetic dose of ketamine 24-hour post-injection on resting state functional connectivity, cognitive control, and reward learning.
Conditions
Sponsors & Collaborators
-
Mclean Hospital
lead OTHER
Principal Investigators
-
Diego Pizzagalli, PhD · Mclean Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-17
- Primary Completion
- 2024-08-28
- Completion
- 2024-08-28
Countries
- United States
Study Locations
More Related Trials
-
Neural Circuit Effects of Ketamine in Depression
NCT06213324 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Ketamine in Patients With Treatment-resistant Depression
NCT01627782 ·Status: COMPLETED ·Phase: PHASE2
-
Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects
NCT02669043 ·Status: TERMINATED ·Phase: NA
-
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
NCT05327699 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Ketamine for Treatment Resistant MDD
NCT04021433 ·Status: UNKNOWN ·Phase: NA
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT05991232 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ketamine Plus Lithium in Treatment-Resistant Depression
NCT01880593 ·Status: COMPLETED ·Phase: PHASE2
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Understanding and Treating Suicidal Ideation With Ketamine
NCT06891300 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ketamine for Depression Relapse Prevention Following ECT
NCT02414932 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ketamine in Adolescents With Treatment-Resistant Depression
NCT02078817 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression
NCT02037503 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712 ·Status: UNKNOWN ·Phase: PHASE4
-
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
NCT02522377 ·Status: COMPLETED ·Phase: NA
-
Ketamine for Depression: An MRI Study
NCT02544607 ·Status: COMPLETED ·Phase: PHASE4
-
Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide
NCT03666390 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
NCT02992496 ·Status: UNKNOWN ·Phase: PHASE2
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
NCT03065335 ·Status: RECRUITING ·Phase: PHASE1
-
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
NCT06232291 ·Status: COMPLETED
-
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
NCT04234776 ·Status: UNKNOWN ·Phase: PHASE4
-
Glutamate Emotion Memory Study
NCT05809609 ·Status: RECRUITING ·Phase: NA
-
Ketamine Anesthesia for Improvement of Depression in ECT
NCT02752724 ·Status: COMPLETED ·Phase: NA
-
Ketamine for Mood Disorders With Suicidal Ideation
NCT04099771 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
NCT05320107 ·Status: RECRUITING ·Phase: PHASE1
-
Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain
NCT03915938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3